Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Autoimmune disease: Parkinson's drug promotes myelin repair.

Crunkhorn S.

Nat Rev Drug Discov. 2013 Dec;12(12):905. doi: 10.1038/nrd4181. Epub 2013 Nov 15. No abstract available.

PMID:
24232375
2.

Multiple sclerosis: Drug-enhanced remyelination in a multiple sclerosis model.

Bible E.

Nat Rev Neurol. 2013 Dec;9(12):660. doi: 10.1038/nrneurol.2013.225. Epub 2013 Nov 5. No abstract available.

PMID:
24189699
3.

Multiple sclerosis: An old drug plays a new trick.

Wekerle H, Meinl E.

Nature. 2013 Oct 17;502(7471):314-5. doi: 10.1038/nature12694. Epub 2013 Oct 9. No abstract available.

PMID:
24107991
4.

The best basic science paper in MS in 2013: Antimuscarinic therapies in remyelination.

Green AJ.

Mult Scler. 2014 Dec;20(14):1814-6. doi: 10.1177/1352458514558679. Epub 2014 Nov 12. No abstract available.

PMID:
25392329
5.

A regenerative approach to the treatment of multiple sclerosis.

Deshmukh VA, Tardif V, Lyssiotis CA, Green CC, Kerman B, Kim HJ, Padmanabhan K, Swoboda JG, Ahmad I, Kondo T, Gage FH, Theofilopoulos AN, Lawson BR, Schultz PG, Lairson LL.

Nature. 2013 Oct 17;502(7471):327-32. doi: 10.1038/nature12647. Epub 2013 Oct 9.

6.

Downregulating DR6 to drive remyelination.

Popko B.

Nat Med. 2011 Jul 7;17(7):779-80. doi: 10.1038/nm0711-779. No abstract available.

PMID:
21738152
7.

Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.

Najm FJ, Madhavan M, Zaremba A, Shick E, Karl RT, Factor DC, Miller TE, Nevin ZS, Kantor C, Sargent A, Quick KL, Schlatzer DM, Tang H, Papoian R, Brimacombe KR, Shen M, Boxer MB, Jadhav A, Robinson AP, Podojil JR, Miller SD, Miller RH, Tesar PJ.

Nature. 2015 Jun 11;522(7555):216-20. doi: 10.1038/nature14335. Epub 2015 Apr 20.

8.

Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis.

Kerstetter AE, Padovani-Claudio DA, Bai L, Miller RH.

Exp Neurol. 2009 Nov;220(1):44-56. doi: 10.1016/j.expneurol.2009.07.010. Epub 2009 Jul 17.

10.

Estrogen receptor β ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis.

Kumar S, Patel R, Moore S, Crawford DK, Suwanna N, Mangiardi M, Tiwari-Woodruff SK.

Neurobiol Dis. 2013 Aug;56:131-44. doi: 10.1016/j.nbd.2013.04.005. Epub 2013 Apr 17.

11.

Tocopherol derivative TFA-12 promotes myelin repair in experimental models of multiple sclerosis.

Blanchard B, Heurtaux T, Garcia C, Moll NM, Caillava C, Grandbarbe L, Klosptein A, Kerninon C, Frah M, Coowar D, Baron-Van Evercooren A, Morga E, Heuschling P, Nait Oumesmar B.

J Neurosci. 2013 Jul 10;33(28):11633-42. doi: 10.1523/JNEUROSCI.0774-13.2013.

12.

Surprising pleiotropy of nerve growth factor in the treatment of experimental autoimmune encephalomyelitis.

Ransohoff RM, Trebst C.

J Exp Med. 2000 May 15;191(10):1625-30. Review. No abstract available.

13.

Inhibition of rho family functions by lovastatin promotes myelin repair in ameliorating experimental autoimmune encephalomyelitis.

Paintlia AS, Paintlia MK, Singh AK, Singh I.

Mol Pharmacol. 2008 May;73(5):1381-93. doi: 10.1124/mol.107.044230. Epub 2008 Jan 31.

14.

HMG-CoA reductase inhibitor augments survival and differentiation of oligodendrocyte progenitors in animal model of multiple sclerosis.

Paintlia AS, Paintlia MK, Khan M, Vollmer T, Singh AK, Singh I.

FASEB J. 2005 Sep;19(11):1407-21. Erratum in: FASEB J. 2005 Dec;19(14):2088.

PMID:
16126908
15.

Neuregulin in neuron/glial interactions in the central nervous system. GGF2 diminishes autoimmune demyelination, promotes oligodendrocyte progenitor expansion, and enhances remyelination.

Marchionni MA, Cannella B, Hoban C, Gao YL, Garcia-Arenas R, Lawson D, Happel E, Noel F, Tofilon P, Gwynne D, Raine CS.

Adv Exp Med Biol. 1999;468:283-95.

PMID:
10635037
16.

[Promoting myelin repair in disorders such as multiple sclerosis and some types of leukodystrophy: current studies].

Baron-Van Evercooren A, Lachapelle F, Nait-Oumesmar B, Pham-Dinh D.

Rev Neurol (Paris). 2007 May;163(5):523-31. Review. French.

PMID:
17571021
17.

Immunoglobulins treatment in multiple sclerosis and experimental autoimmune encephalomyelitis.

Achiron A, Miron S.

Mult Scler. 2000 Oct;6 Suppl 2:S6-8; discussion S33. Review.

PMID:
11188777
18.

Involvement of JAK/STAT signaling in the effect of cornel iridoid glycoside on experimental autoimmune encephalomyelitis amelioration in rats.

Yin L, Chen Y, Qu Z, Zhang L, Wang Q, Zhang Q, Li L.

J Neuroimmunol. 2014 Sep 15;274(1-2):28-37. doi: 10.1016/j.jneuroim.2014.06.022. Epub 2014 Jun 28.

PMID:
25012120
19.

Growth factors and myelin regeneration in multiple sclerosis.

Webster HD.

Mult Scler. 1997 Apr;3(2):113-20. Review.

PMID:
9291164
20.

Remyelination in multiple sclerosis: a new role for neurotrophins?

Althaus HH.

Prog Brain Res. 2004;146:415-32. Review.

PMID:
14699977

Supplemental Content

Support Center